Biden's vaccine patent waiver just start of global supply challenge

WASHINGTON/VIENNA/TOKYO -- President Joe Biden's decision to back a waiver on patent protections for COVID-19 vaccines lowers one hurdle to broader production, but the specialized skills required in quality control and manufacturing look likely to create another bottleneck.